B细胞融合人肝癌细胞疫苗60Co照射后生长及表型的观察*
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Observation of growth and phenotype of 60Co radiated B-cell-human hepatoma cell fusion vaccine
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨B细胞与人肝癌细胞的融合细胞经60Co照射后的生长和免疫原性相关表型的变化。方法:体外照射后观察融合细胞生长曲线和软琼脂集落形成;体内采用裸鼠成瘤试验,观察体外生长和动物体内成瘤性,应用流式细胞仪检测照射后融合细胞MHC-Ⅰ,MHC-Ⅱ,B7及肝癌抗原(GP75)表达,观察其免疫原性相关表型变化。结果:经60Co照射的融合细胞失去增殖能力,4 d后可见部分细胞死亡,7 d后几乎全部死亡。60Co照射后3 d内MHC-Ⅰ,MHC-Ⅱ,B7及GP75表达无明显变化。结论:经60Co照射后融合细胞失去增殖能力,但3 d内免疫相关表型无明显变化。

    Abstract:

    Objective: To investigate the growth and the immunogenicity-related phenotype of B cell-human hepatoma cell fusion cells after 60Co-radiation. Methods: Growth curve and soft agar colonogenicity of fusion tumor vaccine in vitro, and their tumorigenicity in nude mice in vivo for the radiated cell fusion tumor vaccine were observed. The expression of MHC-Ⅰ,MHC-Ⅱ, B7 and hepatoma-antigen(GP75) that were related to immunogenicity of the radiated fusion tumor vaccine cell were analyzed by flow cytometry. Results: 60Co-radiated fusion cells lost proliferative capacity, partly died on d 4 and almost completely died on d 7,while MHC-Ⅰ,MHC-Ⅱ, B7 and GP75 had no apparent changes in immunogenicity-related phenotype in the first 3 d. Conclusion: 60Co-radiated fusion cells lose proliferative capacity, but they have no apparent changes in immunogenicity-related phenotype in the first 3 d.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭